The 90 day mark is a just a spot on the calendar if BARDA is looking at GNBT's S-1 to be approved and/or progress with the vaccine before committing.
According to BARDA, 90 days is a point when Generex can contact them and check progress on the application.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
-
-
-
-
-
-
-